Citius Oncology - Bathi operasional EBITDA CTOR
Citius Oncology, Inc. (CTOR) is accelerating drug development through AI and robotics to remain competitive in the fierce battle for capital within the biotech sector. The company's consolidated EBITDA on this chart demonstrates the business's actual trajectory, with the metric currently standing at 0.00. Future share price growth depends on the successful implementation of the drug Lymphir and the control of operational marketing expenses.
Citius Oncology (CTOR) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Citius Oncology, Inc.|CTOR - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Citius Oncology Inc.|CTOR - Gunggung utang perusahaan|Utang marang modal buku Citius Oncology|CTOR - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Citius Oncology|Rasio cepet citiusonc.com
- statistik bathi lan rasio pasar:
CTOR - Bathi resik perusahaan|Prakiraan bathi perusahaan Citius Oncology, Inc.|CTOR - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi citiusonc.com|CTOR - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Citius Oncology|CTOR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Citius Oncology|CTOR - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan citiusonc.com|CTOR - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Citius Oncology, Inc.
Pambiji fundamental perusahaan:Citius Oncology Inc CTOR
A conservative investor assesses the fundamental stability of Citius Oncology, Inc. (CTOR) through the lens of the business's ability to generate real cash flow. Analyzing EBITDA fluctuations on the GURU.Markets platform, you can see the operating profit before interest and taxes, which reflects the funding efficiency for elite oncologists and the cost of developing targeted drugs, thereby determining the asset's current investment attractiveness.
Karo sapa Citius Oncology, Inc. saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|Bathi operasional sadurunge ngurangi amortisasi erasca.com ERAS|Bathi operasional EBITDA DCTH (Delcath Systems)|Pendapatan operasional sadurunge ngurangi amortisasi Y-mAbs Therapeutics Inc (YMAB)|AURA: Bathi operasional sadurunge ngurangi amortisasi|Candel Therapeutics - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|ARAY: Bathi operasional EBITDA|SLS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi ACTU|Bathi operasional EBITDA TuHURA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Protara (TARA)|Pendapatan operasional sadurunge ngurangi amortisasi Fate Pharma|Aadi Bioscience - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TCRX|CSBR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi XBiotech Inc.|cel-sci.com (CVM) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi OSTX|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Artiva (ARTV)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Adlai Nortye Ltd. (ANL)|VERU - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|Xilio Therapeutics Inc - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RENB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Mural Oncology plc|KAPA: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi OnKure Therapeutics OKUR|Bathi operasional sadurunge ngurangi amortisasi GDTC|Bathi sadurunge bunga, pajak, lan amortisasi Curis Corp CRIS|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|THAR (tharimmune.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ADVB (Advanced Biomed)|Pendapatan operasional sadurunge ngurangi amortisasi Genprex Inc. (GNPX)|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SBFM (sunshinebiopharma.com) - Bathi operasional sadurunge amortisasi|XBIO: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi salariuspharma.com|Bathi operasional sadurunge ngurangi amortisasi PPBT|AON (AONC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA BGNE|Bathi operasional sadurunge ngurangi amortisasi Checkpoint Therapeutics Inc CKPT|Elevation Oncology - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ICAD (iCAD Inc.)|IKNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Notable Labs Ltd|viracta.com (VIRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MorphoSys Corporation - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
